Closed
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Exercise
Calculated transaction value
$0

Rothblatt Martine A Chairperson & CEO

Transaction date Jun 25, 2026
Public filing date Jun 26, 2026
Filing lag Filed 1 day later

UTHR daily price context

Close on/before transaction
$543.39 Jun 25, 2026
First close after public filing
-- Unavailable
30-day return after filing
-- Through Unavailable

Source details

Reported owner
Not disclosed
Source asset code
Derivative
Security
Stock Option on Common Stock
Quantity / price
9,500 shares @ $0
SEC ownership
Direct
Transaction code
M
Form
4
Filing identifier
0001106578-26-000086
Filing cohort

Transactions in this filing

Showing 13 of 13
Trades
13
Issuers
1
Estimated value
$6.52M
Buys / sales
0 / 11
Transactions reported in the same official filing
Issuer Transaction Traded Value
United Therapeutics Corp UTHR Exercise Jun 25, 2026 $1.29M
United Therapeutics Corp UTHR Sale Jun 25, 2026 $371.78K
United Therapeutics Corp UTHR Sale Jun 25, 2026 $227.84K
United Therapeutics Corp UTHR Sale Jun 25, 2026 $164.46K
United Therapeutics Corp UTHR Sale Jun 25, 2026 $241.61K
United Therapeutics Corp UTHR Sale Jun 25, 2026 $353.96K
United Therapeutics Corp UTHR Sale Jun 25, 2026 $418.76K
United Therapeutics Corp UTHR Sale Jun 25, 2026 $890.75K
United Therapeutics Corp UTHR Sale Jun 25, 2026 $1M
United Therapeutics Corp UTHR Sale Jun 25, 2026 $982.67K
United Therapeutics Corp UTHR Sale Jun 25, 2026 $443.17K
United Therapeutics Corp UTHR Sale Jun 25, 2026 $133.16K
United Therapeutics Corp UTHR Current Exercise Jun 25, 2026 $0